US FDA

Recently Posted Guidance Documents

US FDA sent this email to their subscribers on March 18, 2023.


This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo gOVDELlVERY

Text-only version of this email

If your email program has trouble displaying this email, view as a webpage. US Food and Drug Administration U.S. FOOD DRUG ADMINISTRATION RECENTLY POSTED GUIDANCE DOCUMENTS * 3/17/2023 - Pharmacogenomic Data Submissions * 3/16/2023 - CVM GFI #106 The Use of Published Literature in Support of New Animal Drug Approvals * 3/16/2023 - Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance for Industry: Guidance for Industry * 3/15/2023 - Guidance for Industry: Frequently Asked Questions About Medical Foods - Third Edition * 3/15/2023 - Development of Local Anesthetic Drug Products With Prolonged Duration of Effect * 3/15/2023 - Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers * 3/13/2023 -  * 3/13/2023 -  * 3/10/2023 -  GUIDANCE DOCUMENT SEARCH * Search all FDA official guidance documents and other regulatory guidance feedtwitterfacebookyoutubeflickr Manage Subscriptions  |   |  Help ---------------------------------------------------------------------------------------------------------------------------------- This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA GovDelivery logo gOVDELlVERY
Show all

The Latest Emails Sent By US FDA

More Emails, Deals & Coupons From US FDA

Email Offers, Discounts & Promos From Our Top Stores